Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 16, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Oct 7, 2026Reported sale · Form 4Donald W DeGolyer · $126.2KOpen the filing ↗
- Oct 7, 2026Notice of sale · Form 144DONALD DEGOLYER · Director · $126.1KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1,56611 flagged findings
Reported transactions (Form 4)80since May 23, 2024 · and 25 other holdings
Corporate events (8-K)30since Mar 6, 2024
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-01share offering or dilution eventrecentOpen filing ↗“…March 31, 2026, the Company utilized $ 9.1 million, including commissions and excise taxes, to repurchase 0.9 million shares. The…”
+1 more passage from the same document
- “…( 32.2 ) Income taxes receivable and payable, net 4.6 ( 8.4 ) Contract liabilities 3.2 ( 0.3 ) Net cash used in operating activities…”
- 2026-05-01capital return (buybacks/dividends)recentOpen filing ↗“…Stock-based compensation expense, net of forfeitures was recorded in the following financial statement line items: Three Months…”
+1 more passage from the same document
- “…sales, net $ 0.5 $ 0.3 Research & development 0.2 0.2 Selling, general and administrative 1.2 1.0 Total stock-based compensation…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 1,566)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 16, 268-K ↗Current report · A senior executive left or was appointed new
- Oct 7, 26Form 144 ↗Notice of proposed sale
- Oct 1, 26Form 144 ↗Notice of proposed sale
- Sep 14, 268-K ↗Current report · Communication to the market
- Sep 1, 268-K ↗Current report · Other events
- Aug 14, 26SCHEDULE 13G ↗Passive stake · American Century Investment Management, Inc. · 5.4% · event on Jun 30, 26
- Aug 12, 26Form 3 ↗Insider transaction
- Aug 6, 2610-Q ↗Quarterly report
- Aug 5, 268-K ↗Current report · Restructuring plan with committed costs
- Jul 31, 26SCHEDULE 13G/A ↗Passive stake · Vanguard Capital Management · 4.9% · event on Jun 30, 26 · amendment
- Jul 28, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 9.0% · event on Jun 30, 26 · amendment
- Jul 2, 26Form 4 ↗Insider transaction
- Jul 1, 26Form 144 ↗Notice of proposed sale
- Jun 29, 268-K ↗Current report · Entered a material agreement
Insider transaction · 9 Form 4 filingsshow all 9hide
- Jun 10, 26Form 4 ↗Insider transaction
- Jun 10, 26Form 4 ↗Insider transaction
- Jun 10, 26Form 4 ↗Insider transaction
- Jun 10, 26Form 4 ↗Insider transaction
- May 4, 26Form 4 ↗Insider transaction
- May 4, 26Form 4 ↗Insider transaction
- May 4, 26Form 4 ↗Insider transaction
- May 4, 26Form 4 ↗Insider transaction
- May 4, 26Form 4 ↗Insider transaction
1,566 filings on record, the oldest from Nov 14, 06.
Listing the 25 most recent filings of the 1,566 on record.
612068
- Oct 16, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Aug 5, 26Restructuring plan with committed costs+4 more in the same filing8-K 2.05 ↗
- Jun 29, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Apr 17, 26Sold unregistered shares+4 more in the same filing8-K 3.02 ↗
- Mar 3, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Nov 12, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Sep 11, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 4, 24A senior executive left or was appointed8-K 5.02 ↗
- Oct 2, 24Took on a new financial obligation+4 more in the same filing8-K 2.03 ↗
- Sep 17, 24Sold unregistered shares8-K 3.02 ↗
- Sep 3, 24Entered a material agreement+6 more in the same filing8-K 1.01 ↗
- Jul 31, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
9 older filings not shown · The record reaches back to Dec 27, 06.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- May 1, 24Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
- Nov 24, 23Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Nov 16, 23Past accounts declared unreliable and being restated8-K 4.02 ↗
- Aug 8, 23Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
- Jan 9, 23Restructuring plan with committed costs+4 more in the same filing8-K 2.05 ↗
The full record holds 6 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- BlackRock, Inc.9.0%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
- The Vanguard Group6.8%Dec 31, 25SCHEDULE 13G/A ↗
- American Century Investment Management, Inc.5.4%Jun 30, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Dimensional Fund Advisors LP5.3%Mar 31, 26SCHEDULE 13G ↗
- STATE STREET CORPORATION5.1%Dec 31, 25SCHEDULE 13G ↗
show one more holderhide
- Vanguard Capital Management4.9%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Oct 7, DONALD DEGOLYER filed notice of intent to sell up to $126K. That is about 0.03% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $126K on Oct 7, per their Form 4. That is 100% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+2 more recent notices · 2 with a later sale
- Oct 7, 26Sell$126KDonald W DeGolyer↗
- Oct 1, 26Sell$20KPaul Anthony WilliamsSVP, Products Business↗
- Jul 1, 26Sell$25KPaul Anthony WilliamsSVP, Products Business↗
- May 1, 26Sell$107KSujata Tyagi Dayal↗
- May 1, 26Sell$9KSujata Tyagi Dayal↗
- May 1, 26Sell$121KDonald W DeGolyer↗
- May 1, 26Sell$9KDonald W DeGolyer↗
- May 1, 26Sell$135KKathryn C Zoon↗
- May 1, 26Sell$9KKathryn C Zoon↗
- Apr 30, 26Sell$128KKeith Katkin↗
- Apr 1, 26Sell$34KPaul Anthony WilliamsSVP, Products Business↗
Stock compensation, tax and giftsshow the 29 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Jun 8, 26Tax$32KRICHARD S LINDAHLEVP, Chief Financial Officer↗
- Jun 8, 26Tax$16KColeen GlessnerEVP, Quality & Ethics, and CPL↗
- Jun 8, 26Tax$6KPaul Anthony WilliamsSVP, Products Business↗
- Jun 8, 26Tax$14KWilliam HartzelSVP, Bioservices↗
- Apr 30, 26Compensationamount n/aJOHN D FOWLER JR↗
- Apr 30, 26Compensationamount n/aKeith Katkin↗
- Apr 30, 26Compensationamount n/aRonald Richard↗
- Apr 30, 26Compensationamount n/aZsolt HarsanyiChairman↗
- Apr 30, 26Compensationamount n/aMarvin L White↗
- Apr 30, 26Compensationamount n/aNeal Franklin Fowler↗
- Apr 30, 26Compensationamount n/aSujata Tyagi Dayal↗
- Apr 30, 26Compensationamount n/aDonald W DeGolyer↗
- Apr 30, 26Compensationamount n/aKathryn C Zoon↗
- Apr 29, 26Compensationamount n/aRICHARD S LINDAHLEVP, Chief Financial Officer↗
- Apr 29, 26Compensationamount n/aJOSEPH C PAPAPresident and CEO↗
- Apr 29, 26Compensationamount n/aColeen GlessnerEVP, Quality & Ethics, and CPL↗
- Apr 29, 26Compensationamount n/aPaul Anthony WilliamsSVP, Products Business↗
- Apr 29, 26Compensationamount n/aWilliam HartzelSVP, Bioservices↗
- Apr 29, 26Compensationamount n/aJessica PerlSVP, General Counsel, Corp Sec↗
- Apr 29, 26Compensationamount n/aSimon C LowrySVP, R&D, CMO↗
- Mar 5, 26Tax$200KRICHARD S LINDAHLEVP, Chief Financial Officer↗
- Mar 5, 26Tax$313KJOSEPH C PAPAPresident and CEO↗
- Mar 5, 26Tax$69KColeen GlessnerEVP, Quality & Ethics, and CPL↗
- Mar 5, 26Tax$79KPaul Anthony WilliamsSVP, Products Business↗
- Mar 5, 26Tax$80KWilliam HartzelSVP, Bioservices↗
- Mar 5, 26Tax$55KJessica PerlSVP, General Counsel, Corp Sec↗
- Mar 5, 26Tax$90KSimon C LowrySVP, R&D, CMO↗
- Mar 3, 26Compensation$45KJOHN D FOWLER JR↗
- Mar 1, 26Tax$6KRICHARD S LINDAHLEVP, Chief Financial Officer↗
The full record holds 211 transactions and goes back to Jan 9, 23.
Its sector and its market
Emergent BioSolutions Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Emergent BioSolutions Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Emergent BioSolutions Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 1,566 documents on file, from Nov 14, 2006 to Oct 16, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.